Trump Treatment Thrusts Regeneron Virus Drug to Center Stage
- Trump got experimental drug after compassionate use request
- Regeneron reported promising trial results this week
This article is for subscribers only.
Regeneron Pharmaceuticals Inc. has found itself in the spotlight after President Donald Trump was treated with the company’s experimental antibody treatment for Covid-19, just days after the unveiling of promising preliminary trial results.
The Tarrytown, New York-based biotechnology company said it had provided a single high dose of the drug for Trump after receiving a compassionate-use request from his doctors. Trump is at higher risk of severe Covid-19 complications due to his age and clinical obesity.